Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO Trial

Documenti analoghi

• British randomised controlled trial of AV and VV optimization (“BRAVO”) study: rationale, design, and endpoints
  di: Whinnett, Zachary I, et al.
  Pubblicazione: (2014)
• A systematic approach to designing reliable VV optimization methodology: Assessment of internal validity of echocardiographic, electrocardiographic and haemodynamic optimization of cardiac resynchronization therapy
  di: Kyriacou, Andreas, et al.
  Pubblicazione: (2013)
• Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally()
  di: Kyriacou, Andreas, et al.
  Pubblicazione: (2014)
• Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant
  di: Sohaib, S.M. Afzal, et al.
  Pubblicazione: (2015)
• Distinct impacts of heart rate and right atrial‐pacing on left atrial mechanical activation and optimal AV delay in CRT
  di: Kyriacou, Andreas, et al.
  Pubblicazione: (2018)